ICD-10-CM Diagnosis Code T36.8X5 - Adverse effect of other systemic antibiotics (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- S00–T88
- T36-T50
- T36
- 2026 ICD-10-CM Code T36.8X5
Adverse effect of other systemic antibiotics
ICD-10-CM Code:
T36.8X5
ICD-10 Code for:
Adverse effect of other systemic antibiotics
Is Billable?
Not Valid for Submission
Code Navigator:
T36.8X5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity from the list below for a diagnosis of adverse effect of other systemic antibiotics. The code is not specific and is NOT valid for the year 2026 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Non-specific codes like T36.8X5 require more digits to indicate the appropriate level of specificity. Consider using any of the following billable codes with a higher level of specificity when coding for adverse effect of other systemic antibiotics:
Use T36.8X5A for initial encounter
Use T36.8X5D for subsequent encounter
Use T36.8X5S for sequela
- Code Information
- Specific Coding
- Approximate Synonyms
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Injury, poisoning and certain other consequences of external causes
S00–T88
The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.
4-quinolones adverse reaction
Acrosoxacin adverse reaction
Adverse reaction to sulfamethoxazole and/or trimethoprim
Antituberculous drug adverse reaction
Capreomycin adverse reaction
Ciprofloxacin adverse reaction
Ciprofloxacin corneal deposits
Clindamycin adverse reaction
Colistin adverse reaction
Drug-induced corneal epithelial deposit
Drug-induced disorder of cornea
Enoxacin adverse reaction
Erythroderma caused by drug
Erythroderma caused by vancomycin
Fosfomycin adverse reaction
Fusidic acid adverse reaction
Lincomycin adverse reaction
Norfloxacin adverse reaction
Ofloxacin adverse reaction
Polymyxin B adverse reaction
Polymyxins adverse reaction
Teicoplanin adverse reaction
Temafloxacin adverse reaction
Vancomycin adverse reaction
Capreomycin
cyclic peptide antibiotic similar to viomycin. it is produced by streptomyces capreolus.
Ciprofloxacin
a broad-spectrum antimicrobial carboxyfluoroquinoline.
Clindamycin
an antibacterial agent that is a semisynthetic analog of lincomycin.
Colistin
cyclic polypeptide antibiotic from bacillus colistinus. it is composed of polymyxins e1 and e2 (or colistins a, b, and c) which act as detergents on cell membranes. colistin is less toxic than polymyxin b, but otherwise similar; the methanesulfonate is used orally.
Enoxacin
a broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to nalidixic acid.
Enviomycin
cyclic basic peptide related to viomycin. it is isolated from an induced mutant of streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.
Fleroxacin
a broad-spectrum antimicrobial fluoroquinolone. the drug strongly inhibits the dna-supercoiling activity of dna gyrase.
Fosfomycin
an antibiotic produced by streptomyces fradiae.
Fusidic Acid
an antibiotic isolated from the fermentation broth of fusidium coccineum. (from merck index, 11th ed). it acts by inhibiting translocation during protein synthesis.
Lincomycin
an antibiotic produced by streptomyces lincolnensis var. lincolnensis. it has been used in the treatment of staphylococcal, streptococcal, and bacteroides fragilis infections.
Norfloxacin
a synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. norfloxacin inhibits bacterial dna gyrase.
Levofloxacin
the l-isomer of ofloxacin.
Ofloxacin
a synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial dna gyrase, halting dna replication.
Ristocetin
an antibiotic mixture of two components, a and b, obtained from nocardia lurida (or the same substance produced by any other means). it is no longer used clinically because of its toxicity. it causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.
von Willebrand Factor
a high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor viii/von willebrand factor complex. the von willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. it functions in adhesion of platelets to collagen and hemostatic plug formation. the prolonged bleeding time in von willebrand diseases is due to the deficiency of this factor.
Teicoplanin
lipoglycopeptide antibiotic from actinoplanes teichomyceticus active against gram-positive bacteria. it consists of five major components each with a different fatty acid moiety.
Vancomycin
antibacterial obtained from streptomyces orientalis. it is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Vancomycin Resistance
nonsusceptibility of bacteria to the action of vancomycin, an inhibitor of cell wall synthesis.
Vancomycin-Resistant Enterococci
strains of the genus enterococcus that are resistant to the antibiotic vancomycin. the enterococci become resistant by acquiring plasmids carrying genes for vancomycin resistance.
Vancomycin-Resistant Staphylococcus aureus
isolates of the staphylococcus aureus that are resistant to the antibiotic vancomycin. the s. aureus becomes resistant by acquiring plasmids carrying genes for vancomycin resistance. vancomycin‐intermediate s. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. these s. aureus with reduced susceptibility to vancomycin and related glycopeptide antibiotics are often seen in healthcare associated infections.
Viomycin
a strongly basic peptide, antibiotic complex from several strains of streptomyces. it is allergenic and toxic to kidneys and the labyrinth. viomycin is used in tuberculosis as several different salts and in combination with other agents.
Streptogramin A
a specific streptogramin group a antibiotic produced by streptomyces graminofaciens and other bacteria.
Virginiamycin
a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. loidensis, s. mitakaensis, s. pristina-spiralis, s. ostreogriseus, and others. it consists of 2 major components, virginiamycin factor m1 and virginiamycin factor s1. it is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Filter table of drugs and chemicals:
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
What is a drug interaction?
A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:
- Two drugs, such as aspirin and blood thinners
- Drugs and food, such as statins and grapefruit
- Drugs and supplements, such as gingko and blood thinners
- Drugs and medical conditions, such as aspirin and peptic ulcers
Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.
What are side effects?
Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.
What are drug allergies?
Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.
How can I stay safe when taking medicines?
When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.